Steve Kerrigan
@stevewkerrigan
Professor, Sepsis Research Investigator, Founder/CSO of Inthelia Therapeutics, Raising sepsis awareness, Deputy Head of RCSI School of Pharmacy (Research),
ID: 265338221
13-03-2011 11:32:07
356 Tweet
498 Takipçi
345 Takip Edilen
Congratulations James ODonnell
Professor Steve Kerrigan from RCSI School of Pharmacy and Biomolecular Sciences has been researching #sepsis for 25 years. In this piece for #WorldSepsisDay he speaks to RTÉ News about raising awareness of the illness and how it is caused. ⬇️ rte.ie/news/health/20…
Delighted to be attending @scienceirel summit 2023. Looking forward to many interesting conversations and discussions about the high impact of scientific research in Ireland. RCSI School of Pharmacy and Biomolecular Sciences RCSI RCSI Research and Innovation
RCSI spin-out Inthelia Therapeutics founded by Prof Steve Kerrigan RCSI School of Pharmacy and Biomolecular Sciences features in today's The Irish Times. Read how Inthelia Therapeutics is taking a new approach to tackling #sepsis, which accounts for half of all hospital fatalities ➡️ irishtimes.com/business/innov… #RCSIdiscover
Fantastic new innovative and interactive website, well done RCSI School of Pharmacy and Biomolecular Sciences spin out company #inthelia it looks fantastic. RCSI RCSI School of Pharmacy and Biomolecular Sciences Enterprise Ireland RCSI Research and Innovation
Thrilled to be announced as the winner of the Investnet Future Health Summit 2024 Innovation Award, sponsored by UPMC. RCSI RCSI Research and Innovation RCSI School of Pharmacy and Biomolecular Sciences
Know the signs and symptoms of sepsis, if it doesn't feel right it probably isn't ... RCSI RCSI Research and Innovation RCSI School of Pharmacy and Biomolecular Sciences Sepsis: why this deadly condition is so hard to diagnose theconversation.com/sepsis-why-thi… via The Conversation